Login / Signup

Model-based analysis of treatment effects of paclitaxel microspheres in a microscopic peritoneal carcinomatosis model in mice.

Feifan XieKaat De ClercqChris VervaetJan Van BocxlaerPieter ColinAn Vermeulen
Published in: Pharmaceutical research (2019)
The model predicts that the dose range of 7.5-15 mg/kg of PTXnano-GP-MS provides an optimal balance between efficacy and safety.
Keyphrases
  • mass spectrometry
  • multiple sclerosis
  • ms ms
  • type diabetes
  • metabolic syndrome
  • skeletal muscle
  • molecularly imprinted